Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C38H37F3N6O3 |
| Molecular Weight | 682.734 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC(=CC=C1OC[C@@H]2CO[C@](CN3C=NC=N3)(C2)C4=CC=C(F)C=C4F)N5CCN(CC5)C6=CC=C(C=C6)C(=O)NC7=CC=C(F)C=C7
InChI
InChIKey=OSAMZQJKSCAOHA-CWRQMEKBSA-N
InChI=1S/C38H37F3N6O3/c1-26-18-33(46-16-14-45(15-17-46)32-9-2-28(3-10-32)37(48)44-31-7-4-29(39)5-8-31)11-13-36(26)49-21-27-20-38(50-22-27,23-47-25-42-24-43-47)34-12-6-30(40)19-35(34)41/h2-13,18-19,24-25,27H,14-17,20-23H2,1H3,(H,44,48)/t27-,38+/m1/s1
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
824121
Created by
admin on Wed Apr 02 11:38:26 GMT 2025 , Edited by admin on Wed Apr 02 11:38:26 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C158821
Created by
admin on Wed Apr 02 11:38:26 GMT 2025 , Edited by admin on Wed Apr 02 11:38:26 GMT 2025
|
PRIMARY | |||
|
KL-24
Created by
admin on Wed Apr 02 11:38:26 GMT 2025 , Edited by admin on Wed Apr 02 11:38:26 GMT 2025
|
PRIMARY | |||
|
45LU8Q6ASU
Created by
admin on Wed Apr 02 11:38:26 GMT 2025 , Edited by admin on Wed Apr 02 11:38:26 GMT 2025
|
PRIMARY | |||
|
121383526
Created by
admin on Wed Apr 02 11:38:26 GMT 2025 , Edited by admin on Wed Apr 02 11:38:26 GMT 2025
|
PRIMARY | |||
|
11612
Created by
admin on Wed Apr 02 11:38:26 GMT 2025 , Edited by admin on Wed Apr 02 11:38:26 GMT 2025
|
PRIMARY | INN | ||
|
1931946-73-4
Created by
admin on Wed Apr 02 11:38:26 GMT 2025 , Edited by admin on Wed Apr 02 11:38:26 GMT 2025
|
PRIMARY | |||
|
300000032291
Created by
admin on Wed Apr 02 11:38:26 GMT 2025 , Edited by admin on Wed Apr 02 11:38:26 GMT 2025
|
PRIMARY |
ACTIVE MOIETY